HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
Pancreatic cancer is intractable due to early progression and resistance to conventional therapy. Dense fibrotic stroma, known as desmoplasia, is a characteristic feature of pancreatic cancer, and develops through the interactions between pancreatic cancer cells and stromal cells, including pancreat...
Main Authors: | Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/2/411 |
Similar Items
-
Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition
by: Shin Hamada, et al.
Published: (2021-02-01) -
Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma
by: Feilong Chen, et al.
Published: (2022-09-01) -
Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
by: Leah Davis, et al.
Published: (2022-02-01) -
NRF2 pathway activation by KEAP1 inhibition attenuates the manifestation of aging phenotypes in salivary glands
by: Sisca Meida Wati, et al.
Published: (2020-09-01) -
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
by: Farhad Pouremamali, et al.
Published: (2022-06-01)